Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE1193.7021.2 (+1.81 %)

PREV CLOSE ( ) 1172.50

OPEN PRICE ( ) 1171.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12937

TODAY'S LOW / HIGH ( )1169.65 1199.40

52 WK LOW / HIGH ( )994.35 1364.95

NSE1195.1022.9 (+1.95 %)

PREV CLOSE( ) 1172.20

OPEN PRICE ( ) 1175.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1195.10 (1112)

VOLUME 670100

TODAY'S LOW / HIGH( ) 1170.40 1199.50

52 WK LOW / HIGH ( )1010 1356.2

TRENDS

Particulars	Sep 2025	Jun 2025	Var%	Mar 2025	Dec 2024	Var%
Promoter and Promoter Group
Indian Promoters	48.75	48.75	0	48.75	48.75	0
Individuals / Hindu Undivided Family	12.15	12.15	0	12.15	12.15	0
Central Government/State Government(s)
Bodies Corporate	36.6
Financial Institutions / Banks
Partnership Firms
Promoter Group
Employees Welfare Fund
Other		36.6	100	36.6	36.6	0
Any Others (Specify)
Foreign Promoters	3.07	3.07	0	3.07	3.07	0
Non-Residents Individuals / Foreign Individuals	3.07	3.07	0	3.07	3.07	0
'Bodies Corporate
Institutions
Other
Any Others (Specify)
Total of Promoter and Promoter Group	51.82	51.82	0	51.82	51.82	0
Public Shareholding
Institutions	41.81	41.3	1.23	41.56	41.49	0.02
Mutual Funds / UTI	19.3	18.96	1.79	18.21	17.81	0.22
Financial Institutions / Banks
Insurance Companies	5.87	5.49	6.92	5.44	5.12	0.63
Foreign Institutional Investors
Venture Capital Funds
Foreign Venture Capital Investors
Alternate Investment Funds	0.32	0.38	15.79	0.38	0.36	0.56
Foreign Portfolio investors	14.21	14.38	1.18	15.33	16.29	0.59
Provident funds / Pension funds	2.11	2.1	0.48	2.2	1.92	1.46
Multilateral & Bileteral Development Financial Institution
Any Others (Specify)
Central Government / State Government(s)
Foreign Financial Institutions / Banks
Stressed Assets Stabilisation Fund
Foreign Financial Institutions
State Finance Corporation
Foreign Bodies DR
Other
Non-Institutions	6.38	6.87	7.13	6.61	6.69	0.12
Bodies Corporate	0.46	0.48	4.17	0.44	0.46	0.43
Individuals
Individual shareholders holding nominal share capital up to Rs. 1 lakh	4.92	5.34	7.87	5.14	5.23	0.17
Individual shareholders holding nominal share capital in excess of Rs. 1 lakh	0.33	0.33	0	0.33	0.29	1.38
NBFCs Registed with RBI
Employee Trusts
Any Others (Specify)		0.15	100		0.14	10
Clearing Members
Non Resident Indians	0.36	0.42	14.29	0.41	0.4	0.25
Directors & their Relatives & Friends
Foreign Collaborators
Foreign Mutual Fund
Trusts
Hindu Undivided Families	0.14	0.15	6.67	0.14	0.14	0
Foreign Corporate Bodies
Shares in transit
Market Maker
ESOP/ESOS/ESPS
Societies
Escrow Account
Any Other	0.16	0.16	0	0.15	0.15	0
Total Public Shareholding	48.18	48.18	0	48.18	48.18	0

Total of Promoter and Public Shareholding	100	100	0	100	100	0

Shares held by Custodians and against which Depository Receipts have been issued
American Depository Receipts
GDRs
Others

Grand Total	100	100	0	100	100	0

Risk Disclosures on Derivatives

Share Holdings

AUROBINDO PHARMA LTD.